COLL insider trading
NasdaqGS HealthcareCOLLEGIUM PHARMACEUTICAL, INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About COLLEGIUM PHARMACEUTICAL, INC
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Company website: www.collegiumpharma.com
COLL insider activity at a glance
FilingIQ has scored 603 insider transactions for COLL since May 14, 2015. The most recent filing in our index is dated May 11, 2026.
Across the full history, 1 open-market purchases
and 186 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on COLL insider trades is 64.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest COLL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding COLL
Frequently asked
- How many insider trades does FilingIQ track for COLL?
- FilingIQ tracks 603 Form 4 insider transactions for COLL (COLLEGIUM PHARMACEUTICAL, INC), covering filings from May 14, 2015 onwards. 8 of those were filed in the last 90 days.
- Are COLL insiders net buyers or net sellers?
- Across the full Form 4 history for COLL, 1 transactions (0%) were open-market purchases and 186 (31%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does COLL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is COLL in?
- COLLEGIUM PHARMACEUTICAL, INC (COLL) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.44B.
Methodology & sources
Every COLL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.